拜耳利伐沙班在国内上市了吗？

(Rivaroxaban) is a highly selective new oral anticoagulant that directly inhibits factor Xa, inhibits thrombin generation, and inhibits thrombus formation. Rivaroxaban does not inhibit thrombin, has no effect on platelets, will not aggravate postoperative bleeding, and does not require review of the four coagulation parameters to adjust the dosage. Rivaroxaban has high bioavailability and a long action window. It can be taken once a day and is relatively safe. Clinical trials have confirmed that rivaroxaban significantly reduces the probability of pulmonary embolism in patients undergoing major lower limb orthopedic surgery. There is no effect on age, especially for the elderly, there is no need to adjust the dose, which is more convenient.

The Bayer Group is a large multinational company among the world's top 500. It was founded in Germany by Friedrich Bayer and is headquartered in Leverkusen, Germany. After entering China, through its own development, it has more than 5,000 employees in China. Rivaroxaban is one of the drugs produced by Bayer in Germany. The drug was approved for marketing in Canada and the European Union on September 15 and October 1, 2008 respectively, and was subsequently approved by the FDA for official marketing in the United States in July 2011. There are broad market prospects in the future. So, has Bayer’s Rivaroxaban been launched in the country?

Bayer's rivaroxaban was launched in China in June 2009 under the trade name Xarelto. At present, patients can buy the medicines they need at major hospitals and pharmacies in the country. Not only that, because the drug has been included in the national medical insurance catalog, patients can also enjoy the benefits brought by medical insurance to reimburse part of the cost when purchasing the drug, reducing their own financial burden.

In addition, patients can also choose to contact some professional and formal overseas medical service organizations in China (such as Medical Companion Travel) to obtain more cost-effective Bayer Rivaroxaban. According to Medical Travel, the specifications produced by Bayer in Germany are 20mg*28 tablets/box, and the price is around $400.

Recommended hot articles: /newsDetail/96972.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.